title: Epigenetic manipulation of the immune response: a novel treatment strategy in hematologic malignancies.
authors.affiliation: Centre for Clinical Haematology, Queen Elizabeth Hospital and School of Cancer Studies, University of Birmingham, Birmingham, UK.
authors.forename: Charles
authors.initials: C
authors.lastname: Craddock
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics; D002843:Chromatin / Q000235:genetics / Q000378:metabolism; D018899:CpG Islands / Q000235:genetics; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019175:DNA Methylation / Q000187:drug effects; D044127:Epigenesis, Genetic / Q000187:drug effects*; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D008780:Methyltransferases / Q000037:antagonists & inhibitors*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D009363:Neoplasm Proteins / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics
chemical_list: D000951:Antigens, Neoplasm; D002843:Chromatin; D056572:Histone Deacetylase Inhibitors; C072013:MAGEA3 protein, human; D009363:Neoplasm Proteins; C039854:5-azacytosine; D003596:Cytosine; D008780:Methyltransferases